- Home
- CNTB vs FMY Comparison
CNTB vs FMY Comparison
Compare CNTB & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- FMY
- Stock Information
- Founded
- CNTB 2012
- FMY 2005
- Country
- CNTB United States
- FMY United States
- Employees
- CNTB N/A
- FMY N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- FMY Finance/Investors Services
- Sector
- CNTB Health Care
- FMY Finance
- Exchange
- CNTB Nasdaq
- FMY Nasdaq
- Market Cap
- CNTB 54.4M
- FMY 50.5M
- IPO Year
- CNTB 2021
- FMY N/A
- Fundamental
- Price
- CNTB $1.81
- FMY $12.21
- Analyst Decision
- CNTB Strong Buy
- FMY
- Analyst Count
- CNTB 2
- FMY 0
- Target Price
- CNTB $7.50
- FMY N/A
- AVG Volume (30 Days)
- CNTB 168.9K
- FMY 10.1K
- Earning Date
- CNTB 08-13-2025
- FMY 01-01-0001
- Dividend Yield
- CNTB N/A
- FMY 6.98%
- EPS Growth
- CNTB N/A
- FMY N/A
- EPS
- CNTB N/A
- FMY N/A
- Revenue
- CNTB $1,965,000.00
- FMY N/A
- Revenue This Year
- CNTB N/A
- FMY N/A
- Revenue Next Year
- CNTB N/A
- FMY N/A
- P/E Ratio
- CNTB N/A
- FMY N/A
- Revenue Growth
- CNTB N/A
- FMY N/A
- 52 Week Low
- CNTB $0.51
- FMY $10.71
- 52 Week High
- CNTB $2.86
- FMY $12.17
- Technical
- Relative Strength Index (RSI)
- CNTB 46.67
- FMY 50.40
- Support Level
- CNTB $1.77
- FMY $12.09
- Resistance Level
- CNTB $2.46
- FMY $12.28
- Average True Range (ATR)
- CNTB 0.27
- FMY 0.07
- MACD
- CNTB -0.07
- FMY -0.02
- Stochastic Oscillator
- CNTB 5.80
- FMY 49.92
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.